UB Paderborn / Katalog / Suche / in CDI

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Clinical gastroenterology and hepatology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology

PLoS genetics, 2011-01, Vol.7 (1), p.e1001273-e1001273

2011

Link zum Volltext

Verfügbarkeit prüfen

C‐reactive protein: Informative or misleading marker of Crohn's disease?

Inflammatory bowel diseases, 2007-04, Vol.13 (4), p.501-502

Franchimont, Denis

2007

Link zum Volltext

Verfügbarkeit prüfen

Common variants at five new loci associated with early-onset inflammatory bowel disease

Nature genetics, 2009-12, Vol.41 (12), p.1335-1340

2009

Link zum Volltext

Verfügbarkeit prüfen

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-919-S-919

2023

Link zum Volltext

Verfügbarkeit prüfen

Mo1816 NEOPLASTIC LESIONS OUTSIDE DISEASED AREA IN IBD PATIENTS: A NATIONAL COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-935-S-935

2020

Link zum Volltext

Verfügbarkeit prüfen

Sa1864 PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-456-S-456

2020

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn’s Disease in a Randomized Placebo-Controlled Trial

Clinical gastroenterology and hepatology, 2021-08, Vol.19 (8), p.1573-1582.e5

2021

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection

2007-02

Link zum Volltext

Verfügbarkeit prüfen

Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases

Inflammatory bowel diseases, 2022-02, Vol.28 (2), p.208-217

2022

Link zum Volltext

Verfügbarkeit prüfen

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-95-S-96

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

Gut, 2023-11, Vol.72 (11), p.2068

2023

Link zum Volltext

Verfügbarkeit prüfen

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

Human molecular genetics, 2007-12, Vol.16 (24), p.3008-3016

2007

Link zum Volltext

Verfügbarkeit prüfen

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2023-10, Vol.165 (4), p.946-962.e13

2023

Link zum Volltext

Verfügbarkeit prüfen

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

Patient preference and adherence, 2018-01, Vol.12, p.1193-1202

2018

Link zum Volltext

Verfügbarkeit prüfen

Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID

Alimentary Pharmacology & Therapeutics (Suppl), 2021-05, Vol.53 (10), p.1098-1107

2021

Link zum Volltext

Verfügbarkeit prüfen

A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103− dendritic cells

The Journal of experimental medicine, 2009-08, Vol.206 (9), p.1995-2011

2009

Link zum Volltext

Verfügbarkeit prüfen

Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa

Journal of Crohn's and colitis, 2024-04, Vol.18 (4), p.533-539

2024

Link zum Volltext

Verfügbarkeit prüfen

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

The FASEB journal, 2002-01, Vol.16 (1), p.61-71

2002

Link zum Volltext

Verfügbarkeit prüfen

144 – Postoperative Endoscopic and Clinical Recurrence After Ileocolonic Resection in Patients with Crohn's Disease Cannot Be Prevented with High Dose Vitamin D

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-33-S-33

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

United European gastroenterology journal, 2019-07, Vol.7 (6), p.750-758

2019

Link zum Volltext

Verfügbarkeit prüfen

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1208-S-1208

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology

C‐reactive protein: Informative or misleading marker of Crohn's disease?

Common variants at five new loci associated with early-onset inflammatory bowel disease

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Mo1816 NEOPLASTIC LESIONS OUTSIDE DISEASED AREA IN IBD PATIENTS: A NATIONAL COHORT STUDY

Sa1864 PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)

High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn’s Disease in a Randomized Placebo-Controlled Trial

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection

Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID

A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103− dendritic cells

Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn’s Disease

144 – Postoperative Endoscopic and Clinical Recurrence After Ileocolonic Resection in Patients with Crohn's Disease Cannot Be Prevented with High Dose Vitamin D

Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

Aktive Filter

Suchergebnisse filtern